ACMR
ACM Research, Inc.
ACMR has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over ACMR overall, supported by stronger fundamentals.
ACMR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Weak | |
| Healthy |
ACMR's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
ACMR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $24.47 | -51% |
| Forward | 18x | $49.88 | — |
| Fair | 26x | $41.77 | -16% |
| Current | 31x | $49.88 | — |
| Expensive | 74x | $119 | +139% |
Historical ranges are pointers, not guarantees.
ACMR's PE is in its fair range at 31x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over ACMR in the historical PE scenario, which offers more potential upside but is not a forecast.
ACMR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for ACMR, with profitability improving.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
ACMR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.80 | +75% |
| Q3 2026 | $1.60 | -7.5% |
| Q2 2026 | $2.10 | +27% |
| Q1 2026 | $1.31 | -17% |
| Q4 2025 | $1.37 | -10% |
| Q3 2025 | $1.73 | +32% |
| Q2 2025 | $1.66 | +33% |
| Q1 2025 | $1.57 | +20% |
| Q4 2024 | $1.53 | +32% |
ACMR earned $1.60 per share over the past year, down 7.5% from the year before.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over ACMR in the latest year-over-year earnings comparison.
ACMR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $367.7M | +37% |
| Q2 2026 | $292.9M | +36% |
| Q1 2026 | $231.3M | +34% |
| Q4 2025 | $244.4M | +9.4% |
| Q3 2025 | $269.2M | +32% |
| Q2 2025 | $215.4M | +6.4% |
| Q1 2025 | $172.3M | +13% |
| Q4 2024 | $223.5M | +31% |
ACMR's revenue has grown year over year for 18 quarters in a row: $368M last quarter, up 37% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +4.3 points |
| Q2 2026 | 17% | +2.3 points |
| Q1 2026 | 16% | +0.7 points |
| Q4 2025 | 9.4% | -10 points |
| Q3 2025 | 11% | -11 points |
| Q2 2025 | 15% | -3.8 points |
| Q1 2025 | 15% | -1.6 points |
| Q4 2024 | 20% | +6 points |
ACMR's operating margin was 15% last quarter, up 4.3 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK's revenue has grown year over year for six quarters in a row: $11B last quarter, up 378% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over ACMR on profitability, with a higher operating margin.
ACMR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$95.6M | -$80M |
| Q2 2026 | -$71.5M | -$11.8M |
| Q1 2026 | -$51.7M | -$40.3M |
| Q4 2025 | $20.1M | -74% |
| Q3 2025 | -$15.6M | +$5M |
| Q2 2025 | -$59.6M | -223% |
| Q1 2025 | -$11.4M | +$23.6M |
| Q4 2024 | $77.2M | +$122.7M |
ACMR has burned cash in most quarters: −$199M over the past year, against −$10M the year before.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over ACMR on cash generation, producing positive trailing cash flow while its opponent burns cash.
ACMR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.5% | +1.8M shares |
| 1 year | +7.6% | +5.2M shares |
| 3 years | +12% | +8.2M shares |
| 5 years | +13% | +8.2M shares |
| Available history | +28% | +16.2M shares |
ACMR has 74M diluted shares, up 7.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q4 2020 | — |
| Q4 2019 | $2M |
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has the edge over ACMR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
ACMR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.9x | Net Cash |
| Q2 2026 | -4.0x | Net Cash |
| Q1 2026 | -4.0x | Net Cash |
| Q4 2025 | -3.8x | Net Cash |
| Q3 2025 | -5.6x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.5x | Net Cash |
| Q4 2024 | -1.4x | Net Cash |
ACMR has the edge over SNDK on leverage, with a lower net debt burden relative to earnings.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
ACMR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.7 | Neutral |
| Stochastic | 13.7 | Oversold |
ACMR's weekly RSI is 40 (neutral) and its Stochastic is 14 (oversold).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
ACMR PE vs Technology Sector
| Metric | ACMR | Sector median | Relative |
|---|---|---|---|
| PE | 31x | 28x | 12% above |
| PE % | 54 | 35 | 19 pts above |
ACMR is trading at 31x earnings, a 12% premium to the Technology sector's median of 28x.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over ACMR on valuation relative to its sector.
ACMR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $59.5 | 16% below |
| 20 week MA | $72.8 | 31% below |
| 50 week MA | $64.2 | 22% below |
| 100 week MA | $45.4 | 10% above |
| 200 week MA | $31.5 | 58% above |
ACMR has stronger trend alignment. ACMR is above 2 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
ACMR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.13 | $23.2 | +279% |
| 2021 | $23.2 | $25.9 | +11% |
| 2022 | $25.9 | $7.52 | -71% |
| 2023 | $7.52 | $19.5 | +160% |
| 2024 | $19.5 | $15.2 | -22% |
| 2025 | $15.2 | $40.6 | +167% |
| 2026 YTD | $40.6 | $49.9 | +23% |
ACMR's yearly returns have swung widely, from +279% in 2020 to −71% in 2022. It's up 23% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over ACMR on returns for 2026, with the stronger performance.